Novo Nordisk (NOVOB DC) sues Eli lilly (LLY) in US federal court, alleging claim under the Lanham Act, according to court records

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

European Commission will impose its first fine under the DMA on Thursday against Google (GOOGL), fine of up to ten percent of global annual revenue is possible, reports Handelsblatt

Tesco (TSCO LN) announces new partnerships with Uber Eats (UBER), launching in August, and Deliveroo (DASH), which will roll out later this summer

Novo Nordisk (NOVOB DC) sues Eli lilly (LLY) in US federal court, alleging claim under the Lanham Act, according to court records

Charles Schwab (SCHW) Q2 2026 (USD): EPS 1.62 (exp. 1.56), Revenue 7.07bln (exp. 6.90bln)

US PRE-MARKET MOVERS: TSM, NBIS, CCK, DHR, HAS, GM, MMM

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.
  • Is suing over misleading weight loss ads. 

Context

Novo Nordisk's lawsuit against Eli Lilly under the Lanham Act suggests it perceives a competitive threat from misleading advertising claims related to weight loss products. The market may view this as a significant strategic move that could shape consumer perception and competitive dynamics in the pharmaceutical sector, particularly affecting stock performance in both companies and potentially influencing broader sector sentiment.

Related headlines

The feed had this first.

Use the Platform